Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ · Healthcare
Harmony Biosciences Holdings, Inc. Operating Income 2020–2025
Harmony Biosciences Holdings, Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Harmony Biosciences Holdings, Inc. operating income for the quarter ending March 31, 2026 was 37.3 M, a 33.70% decrease year-over-year.
- Harmony Biosciences Holdings, Inc. operating income for the twelve months ending March 31, 2026 was 189.5 M.
- Harmony Biosciences Holdings, Inc. annual operating income for 2025 was 208.5 M, a 9.25% increase from 2024.
- Harmony Biosciences Holdings, Inc. annual operating income for 2024 was 190.8 M, a 0.63% decrease from 2023.
- Harmony Biosciences Holdings, Inc. annual operating income for 2023 was 192.0 M, a 59.78% increase from 2022.
- Harmony Biosciences Holdings, Inc. annual operating income for 2022 was 120.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Harmony Biosciences Holdings, Inc. Operating Income — FAQ
Harmony Biosciences Holdings, Inc. (HRMY) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Harmony Biosciences Holdings, Inc.'s operating income?
Harmony Biosciences Holdings, Inc. (HRMY) reported operating income of $208M for fiscal 2025.
Where can I see HRMY's operating income history?
The chart and table above show Harmony Biosciences Holdings, Inc.'s operating income by year and by quarter, including the growth rate.